New Penn Med AI tool aims to improve clinical decision-making

Roughly 10,000 clinicians across Penn Medicine will now have access to an artificial intelligence chatbot for clinical purposes.

OpenEvidence, a widely-used medical AI and clinical decision-making tool among physicians, announced its partnership with Penn on Tuesday. The tool will be available to Penn Med physicians around the world, including those participating in the University’s ongoing work in Botswana.

“The Botswana-UPenn Partnership is a model for extending cutting edge technologies, such as OpenEvidence, to partners in the global south,” Director and Strategic Advisor for Academic Partnerships in Global Health Farouk Dako wrote in a statement.

According to Dako, the partnership emphasizes collaboration “to ensure appropriate testing and impactful deployment.”

The Botswana-UPenn Partnership is a 25-year-long collaboration focused on improving healthcare capacity in Botswana. It is one of the longest-running academic health partnerships in sub-Saharan Africa.

Get the DP delivered straight to your inbox.